Our key figures
LFB BIOMANUFACTURING developed more than 186 projects of biologics and therapeutics proteins.
More than 50 batches were produced for Phase I and II clinical therapeutics projects from a bioreactor scale between 250L and 1n000L scale
A total of 46 batches were produced at 1,000L scale for Phase III clinical trials.
Since 2020, LFB BIOMANUFACTURING produce the LFB's commercial activated recombinant Factor VII, for certain forms of heamophilia, with more than 70 commercial batches.
More than 50 batches were produced for Phase I and II clinical therapeutics projects from a bioreactor scale between 250L and 1n000L scale
A total of 46 batches were produced at 1,000L scale for Phase III clinical trials.
Since 2020, LFB BIOMANUFACTURING produce the LFB's commercial activated recombinant Factor VII, for certain forms of heamophilia, with more than 70 commercial batches.
♦ 186 therapeutic molecule projects,
♦ Capacity for 6 new projects per year
Regulatory compliance
FDA, EMA and ANSM approved
